To investigate the effects of subliminal micropulse yellow laser application on the central macular thickness and best-corrected visual acuity in cystoid macular edema secondary to retinitis pigmentosa patients. This prospective open-label clinical trial, conducted between January 2018 and October 2019, included 32 eyes of 29 patients who had cystoid macular edema secondary to retinitis pigmentosa. Patients were treated by subliminal micropulse yellow laser for one session. Central macular thickness and best-corrected visual acuity changes were investigated just before the treatment and 1 year later after the one session of the treatment. The mean central macular thickness was 651.3 μm before the treatment and 247.7 μm at 12 months after the treatment. The decrease in mean central macular thickness was statistically significant (p = 0.01). Median best-corrected visual acuity was 66.8 ETDRS letters before the treatment and 70.0 letters at 12 months after the treatment. The increase in best-corrected visual acuity was not statistically significant (p = 0.18). Eighty-six percent of the patients stated that the quality of central vision increased and that color vision, contrast sensitivity, and distortion improved. We did not encounter any serious adverse events related to the application of subliminal micropulse yellow laser. The subliminal micropulse yellow laser seems to be a therapeutic, effective, and safe option for the treatment of non-inflammatory and resistant cystoid macular edema secondary to retinitis pigmentosa patients. ClinicalTrials.gov ID: NCT04234438, January 17, 2020.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
The datasets generated during and/or analyzed during the study are available from the corresponding author on reasonable request.
Hamel C (2006) Retinitis pigmentosa. Orphanet J Rare Dis 1:40
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368(9549):1795–1809
Ali MU, Rahman MSU, Cao J, Yuan PX (2017) Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario. 3 Biotech 7(4):251
El-Asrag ME, Sergouniotis PI, McKibbin M, Plagnol V, Sheridan E et al (2015) Biallelic mutations in the autophagy regulator DRAM2 cause retinal dystrophy with early macular involvement. Am J Hum Genet 96(6):948–954
Adackapara CA, Sunness JS, Dibernardo CW, Melia BM, Dagnelie G (2008) Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina 28:103–110
Hajali M, Fishman GA (2009) The prevalence of cystoid macular edema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 23:915–919
Bakthavatchalam M, Lai FHP, Rong SS, Ng DS, Brelen ME (2018) Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review. Surv Ophthalmol 63(3):329–339
Strong S, Liew G, Michaelides M (2017) Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. Br J Ophthalmol 101(1):31–37
Zhao TT, Tian CY, Yin ZQ (2010) Activation of Müller cells occurs during retinal degeneration in RCS rats. Adv Exp Med Biol 664:575–583
Michalakis S, Schäferhoff K, Spiwoks-Becker I, Zabouri N, Koch S et al (2013) Characterization of neurite outgrowth and ectopic synaptogenesis in response to photoreceptor dysfunction. Cell Mol Life Sci 70(10):1831–1847
Peng YW, Senda T, Hao Y, Matsuno K, Wong F (2003) Ectopic synaptogenesis during retinal degeneration in the royal college of surgeons rat. Neuroscience 119(3):813–820
Peng YW, Hao Y, Petters RM, Wong F (2000) Ectopic synaptogenesis in the mammalian retina caused by rod photoreceptor-specific mutations. Nat Neurosci 3(11):1121–1127
Kolomeyer AM, Zarbin MA (2014) Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. Surv Ophthalmol 59:134–165
O'Neal TB, Luther EE (2019) Retinitis pigmentosa. SourceStatPearls [Internet]. Treasure Island: StatPearls Publishing
Coscas G (ed) (2017) Macular Edema. 2nd, revised and extended edition. Dev Ophthalmol. Basel, Karger, vol 58, pp 191–201
Massengill MT, Ahmed CM, Lewin AS, Ildefonso CJ (2018) Neuroinflammation in retinitis pigmentosa, diabetic retinopathy, and age-related macular degeneration: a minireview. Adv Exp Med Biol 1074:185–191
Nagasaka Y, Ito Y, Ueno S, Terasaki H (2018) Number of hyperreflective foci in the outer retina correlates with inflammation and photoreceptor degeneration in retinitis pigmentosa. Ophthalmol Retina 2(7):726–734
Nishiguchi KM, Yokoyama Y, Kunikata H, Abe T, Nakazawa T (2019) Correlation between aqueous flare and residual visual field area in retinitis pigmentosa. Br J Ophthalmol 103(4):475–480
Kohno H, Chen Y, Kevany BM, Pearlman E, Miyagi M et al (2013) Photoreceptor proteins initiate microglial activation via toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal. J Biol Chem 288(21):15326–15341
Deng WL, Gao ML, Lei XL, Lv JN, Zhao H et al (2018) Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Rep 10(4):1267–1281
Grigoropoulos VG, Emfietzoglou J, Nikolaidis P, Chatzistefanou K, Vergados J et al (2010) Optical coherence tomography findings in patients with retinitis pigmentosa and low visual acuity. Ophthalmic Surg Lasers Imaging 41:35–39
Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107:1445–1452
Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17:222–231
Newsome DA, Blacharski PA (1987) Grid photocoagulation for macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 103:161–166
Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H (2009) Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. J Ocul Pharmacol Ther 25:545–550
Örnek N, Örnek K, Erbahçeci İE (2016) Intravitreal dexamethasone implant (ozurdex) for refractory macular edema secondary to retinitis pigmentosa. Turk J Ophthalmol 46(4):179–181
Garcia-Arumi J, Martinez V, Sararols L, Corcostegui B (2003) Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology 110:1164–1169
Değirmenci MFK, Demirel S, Batıoğlu F, Özmert E (2018) Short-term efficacy of micropulse yellow laser in noncenter-involving diabetic macular edema: preliminary results. Turk J Ophthalmol 48:245–249
Scholz P, Altay L, Fauser S (2017) A review of subthreshold micropulse laser for treatment of macular disorders. Adv Ther 34(7):1528–1555
Luttrull K (2018) Improved retinal and visual function following panmacular subthreshold diode micropulse laser for retinitis pigmentosa. Eye 32:1099–1110
Gao X, Xing D (2009) Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci 16:4
Iwami H, Pruessner J, Shiraki K, Brinkmann R, Miura Y (2014) Protective effect of a laser induced sub-lethal temperature rise on RPE cells from oxidative stress. Exp Eye Res 124:37–47
Inagaki K, Shuo T, Katakura K, Ebihara N, Murakami A, Ohkoshi K (2015) Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells. J Ophthalmol 729792
Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122(11):4213–4217
Koenekoop RK (2011) Why some photoreceptors die,while others remain dormant: lessons from RPE65 and LRAT associated retinal dystrophies. Ophthalmic Genet 32(2):126–128
Wong F, Kwok SY (2016) The survival of cone photoreceptors in retinitis pigmentosa. JAMA Ophthalmol 134(3):249–250
Wang W, Lee SJ, Scott PA, Lu X, Emery D et al (2016) Two-step reactivation of dormant cones in retinitis pigmentosa. Cell Rep (2):372–385 10
We thank the participants of the study. We would like to thank Prof. Dr. Emin ÖZMERT for the training and support on micropulse laser applications.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics committee approval for the subliminal micropulse laser study was obtained from the Ankara University Faculty of Medicine Clinical Research Ethics Committee (20-1249-17). The study was performed in accordance with the tenets of the 2013 Declaration of Helsinki. Written informed consent was obtained from the patients prior to enrollment.
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Medical writing assistance
Medical writing and editorial assistance was provided by Ali Hariri from the American Manuscript Editors Company, which was funded by the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arslan, U. Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser. Lasers Med Sci 36, 317–323 (2021). https://doi.org/10.1007/s10103-020-03031-0
- Retinitis pigmentosa
- Cystoid macular edema
- Intraretinal cysts
- Subliminal micropulse laser